Bin Pan

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Aortic Dissection

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

American journal of hematology

NPJ Regenerative medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yuekun Qi, Hujun Li, Kunming Qi, Feng Zhu, Hai Cheng, Wei Chen, Zhiling Yan, Depeng Li, Wei Sang, Xiaoming Fei, Weiying Gu, Yuqing Miao, Hongming Huang, Ying Wang, Tingting Qiu, Jianlin Qiao, Bin Pan, Ming Shi, Gang Wang, Zhenyu Li, Junnian Zheng, Kailin Xu, Jiang Cao
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapy. American journal of hematology (2024)
Cong Liu, Qiu Lan, Shuo Cao, Fei Zheng, Yiwen Liang, Jingyi Shen, Ying Wang, Takayuki Ikezoe, Kailin Xu, Bin Pan
Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15. Leukemia 38 (6) (2024)
Cong Liu, Qiu Lan, Shuo Cao, Fei Zheng, Yiwen Liang, Jingyi Shen, Ying Wang, Takayuki Ikezoe, Kailin Xu, Bin Pan
Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15. Leukemia 38 (6) (2024)
Cong Liu, Qiu Lan, Shuo Cao, Fei Zheng, Yiwen Liang, Jingyi Shen, Ying Wang, Takayuki Ikezoe, Kailin Xu, Bin Pan
Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15. Leukemia (2024)
Jingyi Shen, Ying Wang, Fei Zheng, Shuo Cao, Qiu Lan, Kailin Xu, Bin Pan
Aryl hydrocarbon receptor regulates IL-22 receptor expression on thymic epithelial cell and accelerates thymus regeneration. NPJ Regenerative medicine 8 (1) (2023)
Ying Wang, Yang Liu, Xu Tan, Bin Pan, Jian Ge, Kunming Qi, Hai Cheng, Jiang Cao, Ming Shi, Zhiling Yan, Jianlin Qiao, Guangjun Jing, Xue Wang, Wei Sang, Ruixiang Xia, Xi Zhang, Zhenyu Li, Robert Peter Gale, Jun-Nian Zheng, Feng Zhu, Kailin Xu
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection. Leukemia 34 (10) (2020)